ArticleFrontiers in endocrinology2025
Accurate screening of patients with diabetes based on physical examination: pancreas imaging features from chest CT and laboratory data.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Fasting plasma glucose (FBG) was used in the large-scale primary screening of diabetes mellitus (DM). However, some people who actually have DM have normal fasting glucose (NFG), which shows a high false negative rate. Objective: To investigate the application value of pancreatic radiomics features and laboratory data from chest CT scan in screening DM patients. Methods: Patients with DM were diagnosed according to HbA1c≥48 mmol/mol(6.5%). The radiomics features of pancreas in lung window (L) and soft tissue window (S) of chest CT and laboratory data of 3587 patients from D1 (model training and testing) and D2/D3/D4/D5 (external validation) were retrospectively analyzed to construct a diagnostic model for DM screening. Results: The AUC of the lung window-laboratory models (L-Lab-LR and L-Lab-SVM) in the test set were 0.958/0.965. The AUC of soft tissue windows-clinical models (S-Lab-LR and S-Lab-SVM) were 0.958/0.969, 0.875/0.881, 0.935/0.959, 0.905/0.919, respectively. Conclusions: The diagnostic model based on chest CT pancreatic radiomics features and laboratory data has a very high diagnostic efficiency, which is accurate and reliable for the initial screening of DM patients. This method will facilitate early diagnosis of those individuals with DM who may have been missed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.